Suppr超能文献

YKL-40 水平升高与初诊 Graves 病的疾病严重程度相关。

Increased YKL-40 levels are linked with disease severity of initially diagnosed Graves' disease.

机构信息

Department of Endocrinology, Jiangnan University Medical Center, Wuxi, China.

出版信息

Libyan J Med. 2023 Dec;18(1):2212480. doi: 10.1080/19932820.2023.2212480.

Abstract

YKL-40, which is also known as Chitiniase 3-like 1, has been found to be up-regulated in many autoimmune diseases including asthma, systemic sclerosis and systemic lupus, etc. However, the relationship between serum levels of YKL-40 and one another common autoinmmue thyroid disease - Graves' disease (GD) has not yet been investigated. The current study was performed to investigate the correlation of serum YKL-40 levels with disease severity of initially diagnosed GD. A total of 142 newly diagnosed active GD and 137 healthy individuals were enrolled in the study. Methimazole was given to 55 GD patients and then 2-month study of follow-up was performed. A commercial ELISA kit was applied for the detection of YKL-40 in serum. Degree of goiter was assessed according to Pérez's Grade. Receiver operating characteristic (ROC) curve analysis was carried out to detect the diagnostic value of serum YKL-40 with regard to goiter degree. The velocity of the peak systolic blood-flow and the thyroid tissue blood flow (TBF) were examined using Color Flow Doppler ultrasonography (CFDU). The patients with GD exhibited dramatically higher YKL-40 in serum compared to those of healthy controls (606.1 ± 149.8 pg/mL vs. 397.4 ± 95.1 pg/mL,  < 0.001). Positive associations of YKL-40 with free T3 (FT3) and T4 (FT4), as well as the negative correlation of YKL-40 with TSH in serum, were observed. Additionally, the YKL-40 in serum was dramatically reduced after methimazole intervention, and the correlation of the decline with the reduced FT3 and FT4 was also found (all  < 0.001). Serum YKL-40 levels were positively correlated with goiter degree. ROC curve analysis demonstrated that serum YKL-40 concentration may act as a decent marker for goiter degree. The positive correlations of YKL-40 in serum with the average superior thyroid artery velocity (STV) and thyroid tissue blood flow (TBF) were also observed. Our findings implicated that YKL-40 may be closely connected to the pathogenesis of GD. Increased YKL-40 levels are linked with disease severity of initially diagnosed GD.

摘要

YKL-40 又被称为甲壳质酶 3 样蛋白 1,在许多自身免疫性疾病中呈上调表达,包括哮喘、系统性硬皮病和系统性红斑狼疮等。然而,YKL-40 的血清水平与另一种常见的自身免疫性甲状腺疾病——格雷夫斯病(GD)之间的关系尚未被研究。本研究旨在探讨血清 YKL-40 水平与初诊 GD 严重程度的相关性。共纳入 142 例新诊断的活动期 GD 患者和 137 例健康对照者。55 例 GD 患者给予甲巯咪唑治疗,然后进行为期 2 个月的随访研究。采用商业 ELISA 试剂盒检测血清 YKL-40。根据 Pérez 分级评估甲状腺肿程度。采用受试者工作特征(ROC)曲线分析检测血清 YKL-40 对甲状腺肿程度的诊断价值。应用彩色多普勒超声(CFDU)检测甲状腺峰值收缩期血流速度和甲状腺组织血流(TBF)。GD 患者血清 YKL-40 明显高于健康对照组(606.1±149.8 pg/mL 比 397.4±95.1 pg/mL,  < 0.001)。YKL-40 与游离三碘甲状腺原氨酸(FT3)和游离甲状腺素(FT4)呈正相关,与血清 TSH 呈负相关。此外,甲巯咪唑干预后血清 YKL-40 显著降低,且与 FT3 和 FT4 降低呈负相关(均  < 0.001)。血清 YKL-40 水平与甲状腺肿程度呈正相关。ROC 曲线分析表明,血清 YKL-40 浓度可能是甲状腺肿程度的一个较好的标志物。血清 YKL-40 与甲状腺上动脉平均流速(STV)和甲状腺组织血流(TBF)呈正相关。我们的研究结果表明,YKL-40 可能与 GD 的发病机制密切相关。初诊 GD 患者 YKL-40 水平升高与疾病严重程度相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7055/10197980/38a3306f6528/ZLJM_A_2212480_F0001_B.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验